Related Experiment Video
Updated: Jul 29, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Optimizing diastolic filling by pacing in nonobstructive hypertrophic cardiomyopathy
Muthiah Subramanian1, Vijay Shekar1, Preetam Krishnamurthy1
1Department of Cardiology, AIG Institute of Cardiac Sciences and Research, Hyderabad, India.
Insights
Optimized sequential atrioventricular (AV) pacing from the right ventricular apex (RVA) improved diastolic function and functional capacity in patients with nonobstructive hypertrophic cardiomyopathy (nHCM). This pacing strategy offers a new treatment option for nHCM patients.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
- Cardiovascular Imaging
Background:
- Limited treatment options exist for symptomatic patients with nonobstructive hypertrophic cardiomyopathy (nHCM).
- Diastolic dysfunction is a key feature of nHCM, impacting functional capacity.
Purpose of the Study:
- To evaluate the impact of sequential atrioventricular (AV) pacing from various right ventricular (RV) sites and AV delays on diastolic function and functional capacity in nHCM patients.
- To identify optimal pacing parameters for improving cardiac function in nHCM.
Main Methods:
- Prospective enrollment of 21 symptomatic nHCM patients with preserved left ventricular (LV) systolic function.
- Echocardiographic assessment of diastolic function during dual-chamber pacing at different RV sites (apex, midseptum, outflow tract) and AV delays.
- Identification of optimal pacing site and AV delay based on diastolic filling parameters and E/e' ratio.
Main Results:
- RV apex (RVA) pacing at an optimized AV delay significantly improved diastolic function (E/e') in 18 of 21 patients (responders).
- Responders achieved optimal diastolic filling with RVA pacing at sensed AV delays (SAVD) of 130-160 ms.
- Non-responders exhibited longer symptom duration, lower LV ejection fraction, and higher late gadolinium enhancement burden.
- During follow-up, responders showed significant improvements in diastolic function, functional capacity (NYHA class), and N-terminal pro-brain natriuretic peptide levels.
Conclusions:
- Sequential AV pacing from the RVA with an optimized AV delay is an effective strategy for improving diastolic function and functional capacity in a subset of nHCM patients.
- This pacing approach represents a promising therapeutic option for managing symptomatic nHCM.
Background:
Treatment options for symptomatic patients with nonobstructive hypertrophic cardiomyopathy (nHCM) are limited.
Objective:
The purpose of this study was to determine the effect of sequential atrioventricular (AV) pacing, from different right ventricular (RV) sites with varying AV delays, on the diastolic function and functional capacity of patients with nHCM.
Methods:
Twenty-one patients with symptomatic nHCM and normal left ventricular (LV) systolic function were prospectively enrolled. Inclusion criteria included PR interval >150 ms, E/e' ≥15, and an indication for implantable cardioverter-defibrillator (ICD) implantation. Doppler echocardiographic study was performed during dual-chamber pacing at various AV intervals. Pacing was performed at 3 RV sites: RV apex (RVA), RV midseptum (RVS), and RV outflow tract (RVO). The site and sensed AV delay (SAVD) at which optimal diastolic filling occurred were chosen based on diastolic filling period and E/e'. During ICD implantation, the RV lead was implanted at the site identified by the pacing study. Devices were programmed in DDD mode at the optimal SAVD. During follow-up, diastolic function and functional capacity were assessed.
Results:
Among the 21 patients (age 47.8 ± 7.7 years; 81.0% male), baseline E/A and E/e' were 2.4 ± 0.6 and 17.2 ± 2.2, respectively. There was an improvement in diastolic function (E/e') in 18 patients (responders) when pacing from the RVA (12.9 ± 3.4; P <.001) than from the RVS (16.6 ± 2.3) and RVO (16.9 ± 2.2). Among responders, optimal diastolic filling occurred at SAVD of 130-160 ms with RVA pacing. Nonresponders had longer duration of symptoms (P = .006), lower LV ejection fraction (P = .037), and higher late gadolinium enhancement burden (P <.001). During 13.5 ± 1.5 months of follow-up, there was an improvement (Δ) in diastolic function (E/e' -4.1 ± 0.5), functional capacity (New York Heart Association functional class -1.5 ± 0.3), and reduction in N-terminal pro-brain natriuretic peptide level (-55.6 ± 12.3 pg/mL) compared to baseline.
Conclusion:
Pacing at an optimized AV delay from the RVA improves diastolic function and functional capacity in a subset of patients with nHCM.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure V: Medical Management